The Proteasome, a New Target for Cancer Therapy

Publisher： Karger

E-ISSN： 2296-5262|25|6|534-539

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.25, Iss.6, 2003-01, pp. : 534-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mu opioid receptor: A new target for cancer therapy?

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2681-2688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imaging of TKI–Target Interactions for Personalized Cancer Therapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 239-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is ADRM1 a Good Target for Cancer Therapy?

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 86-87

Karger

Access to resources Recommend Favorite

Extracellular HSP90: An Emerging Target for Cancer Therapy

By  

Current Signal Transduction Therapy, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

The ErbB2 Signaling Network as a Target for Breast Cancer Therapy

By Badache Ali   Gonçalves Anthony  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 13-25

Springer Publishing Company

Access to resources Recommend Favorite